Chinese patent medicine only accounts for 5% of the world's share

"In terms of the export of Chinese patent medicine, Japan accounts for 80% of the world's share, while South Korea accounts for 15%, while China, the birthplace of traditional Chinese medicine, accounts for only 3% to 5% Foreign countries import a large number of extracts from China, they buy them at a low price, leave the pollution to China, and then make preparations and sell them back to China Chinese origin, Korean development, Japanese results, European and American harvest Traditional Chinese medicine has many difficulties in the international market " Zhang Qi, executive president of China Development Research Institute, honorary chairman of the world natural medicine organization of the United Nations World Peace Foundation and vice president of Shanghai Creative Industries Association, said at the international health forum and 2013 annual meeting of chief editor of Chinese Medical Encyclopedia held recently Zhang Qi explained that the biggest reason for restricting the internationalization of traditional Chinese medicine lies in that some of the standards originally formulated by the government can not keep up with the development of the situation, and the standards are still low Although they seem to be up to the standards in China, they are seriously not up to the standards once they have been tested abroad, which is quite large, dozens of times, hundreds of times In addition, there are problems in traditional Chinese medicine itself Some traditional Chinese medicine planting enterprises, including some farmers who practice medicine, have almost no awareness of environmental protection In particular, there are some people in traditional Chinese medicine who say that mung beans can be treated for any disease, and there is another one who says that arsenic can cure all diseases, which is to damage themselves According to Zhang Qi, at present, traditional Chinese medicine has no drug status in foreign countries as a whole It is only used as a healthy food No traditional Chinese medicine product has passed drug approval in developed countries in Europe and the United States In addition, due to the influence of product quality, competition strategy and other factors, traditional Chinese medicine mainly meets the demand of domestic market, and its insufficient development in the international market leads to the small share of traditional Chinese medicine in the international herbal market Chinese herbal medicines exported abroad are often processed abroad and then sold back to China, from which foreign enterprises earn high profits Such an export mode is obviously unfavorable to the development of traditional Chinese medicine in China In 2012, the export amount of Chinese herbal extracts was US $1.13 billion, accounting for 48.5% of the export amount of Chinese herbal medicines The export of traditional Chinese medicine and decoction pieces is 700 million US dollars, accounting for 33% of the export of traditional Chinese medicine Gao Sihua, President of Beijing University of traditional Chinese medicine, said that the current situation of the development of international traditional Chinese medicine is more and more acceptance and welcome of traditional Chinese medicine, while traditional Chinese medicine is becoming more and more localized and mainstream In a good environment, the development of Chinese medicine in foreign countries is more and more difficult "There are many key reasons, different cultural cognition, different thinking mode of traditional Chinese medicine and modern thinking mode Secondly, there is the problem of scientific standards and evaluation system At the beginning, traditional Chinese medicine was not used as medicine, but as a food additive But according to the drug standard of food, it has given us great restrictions " Mr Gao said After China's accession to the WTO, the market of traditional Chinese medicine is gradually integrating with the international pharmaceutical market, which has become a part of the international pharmaceutical market, and the market competition is becoming more and more fierce In order to solve the problem of standards, China participated in the establishment of the technical committee of traditional Chinese medicine (ISO / tc249) by the international organization for Standardization in 2009 The Secretariat is located in China, which is a milestone in the history of national standardization of traditional Chinese medicine At the same time, the implementation of gap standard in the process of planting, production and processing of traditional Chinese medicine should be implemented to reduce the heavy metals and residual pesticides contained in traditional Chinese medicine preparations We should strengthen the unified management of the export of traditional Chinese medicine, including the unification of price and quality standards, and reduce the restrictions of trade barriers on the export of traditional Chinese medicine to foreign countries The upcoming Encyclopedia of Chinese medicine is a national key project initiated by more than 40 medical academicians in China and approved by many national leaders in 2008 Besides the comprehensive combing and compilation of traditional Chinese medicine knowledge and basic concepts, it is also one of the standardization and standardization of traditional Chinese medicine.